Sensocure AS is a company with major ambitions in the development and delivery of sensors for medical use. New medical technology developed in the company will be a breakthrough in real-time monitoring of body functions and early detection of organ damage. Insufficient blood supply to vital organs is the most common disease and cause of death in the Western world in terms of stroke, myocardial infarction, trauma, complications after surgery and a variety of other conditions. There is therefore a great need for diagnostics that can trigger early treatment in this area.
Sensocure AS has developed IscAlert™, a body-implantable micro biosensor that can monitor blood flow in the human body organs. The sensor is easy to use and has applications eg in cardiac surgery, vascular surgery, transplant surgery and reconstructive surgery. The sensor technology is patented in many parts of the world and the first version of the sensor is CE marked and FDA approved.
Company Details
- Employees
- 24
- Founded
- -
- Address
- Langmyra 11b, Skoppum,vestfold 3185,norway
- po****@****cure.no
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- sensocure.no
- HQ
- Skoppum, Vestfold
Sensocure As Questions
Sensocure As's website is sensocure.no
Sensocure As's LinkedIn profile is https://no.linkedin.com/company/sensocure-as
Sensocure As has
24 employees.
View email and phone details for 24
employees at Sensocure As.
Sensocure As's industry is
Medical Equipment Manufacturing
Sensocure As's top competitors are
Nordic Brain Tech As,
Ontogeny,
Induvita As,
Deepinsight,
Ortrud Medical Ab,
Norway Health Tech,
Respinor As,
Nordiq Products As,
Glucoset,
Exac As.
Sensocure As's support email address is post@sensocure.no
Sensocure As's categories are Medical Equipment Manufacturing
Sensocure As's founding year is 2011
